DSD-T462

Congenital adrenal hyperplasia (CAH) · 46,XX · DSD-T462

DSD-T462 · Congenital adrenal hyperplasia (CAH) · 2026 · Automated translation

Genes CYP21A2 · Karyotype 46,XX · Phenotypes HPO:0000062, Ambiguous genitalia (HP:0000062)

Simple virilizing 21-hydroxylase deficiency (46,XX DSD), with secondary polycythemia and renal insufficiency associated with hypertestosteronemia.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Sex

Female (atypical genitalia at birth; phallus resection and genital reconstruction at age 7)

Karyotype

46,XX

Genetics

CYP21A2

Phenotypes

Ambiguous genitalia (HP:0000062)

Diagnosis

Simple virilizing 21-hydroxylase deficiency (46,XX DSD), with secondary polycythemia and renal insufficiency associated with hypertestosteronemia.

Follow-up

At 20-month follow-up, creatinine decreased to 70.7 μmol/L, eGFR 101.8 mL/min/1.73 m², UACR 9.5 mg/g, and proteinuria resolved; Hb remained <150 g/L and polycythemia improved.

General phenotype

Marked hyperpigmentation in skin creases (posterior neck, axillae, extensor surfaces of the knuckles); deep voice, muscular build, hirsutism (Ferriman-Gallwey score 16).

Imaging

Adrenal CT showed bilateral adrenal thickening and a single cyst in the right kidney; gynecological ultrasound showed a hypoplastic, small uterus; no cryptorchidism in the inguinal or pelvic regions; liver, pancreas, and spleen ultrasound, echocardiography, and pituitary MRI were normal.

Laboratory findings

Creatinine 100.3–100.6 μmol/L (41–73), uric acid 484–505 μmol/L, eGFR 66.92 mL/min/1.73 m², UACR 146.54 mg/g, UPCR 263.92 mg/g; RBC 6.51×10¹²/L, Hb 208 g/L, EPO normal; testosterone 9.29 ng/mL (0.1–0.75), progesterone >40 ng/mL, 17-OHP 456 ng/mL (0.13–2.41), ACTH 943.5 pg/mL (10.1–57.6), with cortisol, LH, and FSH suppressed.

Management

Erythrocytapheresis was performed first and dexamethasone 0.75 mg/day started; after 2 months switched to prednisone 5 mg/day; at 3 months ACTH rebounded to 645.4 pg/mL and testosterone to 2.65 ng/mL, so treatment was changed back to dexamethasone 0.375 mg/day.

Pathology

Not reported in the original article (patient declined renal biopsy)

Genetic variants

c.1069C>T, c.293-13C>G, p.Arg357Trp

Evidence level

See source

Clinical history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Limitations

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XX · DSD-T462 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T462?version=v1.4.0